The role of muscle in bone repair: The cells, signals, and tissue responses to injury

Current Osteoporosis Reports

Volumn 11, Issue 2, 2013, Pages 130-135

  Shah, Krupa ^a,b   Majeed, Zahraa ^b   Jonason, Jennifer ^a   O'Keefe, Regis J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Bone repair; Fracture; Muscle; Muscle derived stem cells; Osteoprogenitors; Periosteum

Indexed keywords

ANABOLIC AGENT; GROWTH FACTOR; MUSCLE ANABOLIC AGENT; UNCLASSIFIED DRUG;

AGING; ANGIOGENESIS; ARTICLE; BONE; BONE MASS; CARTILAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL TYPE; CHEMOTAXIS; DISEASE SEVERITY; FRACTURE HEALING; HUMAN; LEAN MUSCLE MASS; MUSCLE; MUSCLE DERIVED STEM CELL; NONHUMAN; PERIOSTEUM; SARCOPENIA; STEM CELL; TISSUE DIFFERENTIATION; TISSUE REACTION; VASCULARIZATION;

BONE REMODELING; CELL DIFFERENTIATION; FRACTURE HEALING; FRACTURES, BONE; HUMANS; OSTEOBLASTS; SIGNAL TRANSDUCTION;

EID: 84879097640     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-013-0146-3     Document Type: Article

References (44)

1. Donaldson LJ, Reckless IP, Scholes S, Mindell JS, Shelton NJ. The epidemiology of fractures in England. J Epidemiol Community Health. 2008;62:174-80.
2. Couris CM, Chapurlat RD, Kanis JA, Johansson H, Burlet N, Delmas PD, et al. FRAX(R) probabilities and risk of major osteoporotic fracture in France. Osteoporos Int. 2012;23:2321-7.
3. Wilson CL, Dilley K, Ness KK, Leisenring WL, Sklar CA, Kaste SC, et al. Fractures among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2012;118:5920-8.
4. Wukich DK, Kline AJ. The management of ankle fractures in patients with diabetes. J Bone Joint Surg Am. 2008;90:1570-8.
5. Moghaddam A, Zimmermann G, Hammer K, Bruckner T, Grutzner PA, von Recum J. Cigarette smoking influences the clinical and occupational outcome of patients with tibial shaft fractures. Injury. 2011;42:1435-42.
6. Sloan A, Hussain I, Maqsood M, Eremin O, El-Sheemy M. The effects of smoking on fracture healing. Surgeon. 2010;8:111-6.
7. Alshryda S, Shah A, Odak S, Al-Shryda J, Ilango B, Murali SR. Acute fractures of the scaphoid bone: systematic review and meta-analysis. Surgeon. 2012;10:218-29.
8. Friedrich JB, Katolik LI, Hanel DP. Reconstruction of soft-tissue injury associated with lower extremity fracture. J Am Acad Orthop Surg. 2011;19:81-90.
9. Papakostidis C, Kanakaris NK, Pretel J, Faour O, Morell DJ, Giannoudis PV. Prevalence of complications of open tibial shaft fractures stratified as per the Gustilo-Anderson classification. Injury. 2011;42:1408-15.
10. Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012;8:133-43.
11. • Colnot C, Zhang X, Knothe Tate ML. Current insights on the regenerative potential of the periosteum: molecular, cellular, and endogenous engineering approaches. J Orthop Res. 2012;30:1869-78. The current fracture healing paradigm regards the activation, expansion, and differentiation of periosteal stem/progenitor cells as an essential step in building a template for subsequent neovascularization, bone formation, and remodeling. Periosteal cells contribute more to cartilage and bone formation within the callus during fracture healing than do cells of the bone marrow or endosteum, which do not migrate out of the marrow compartment.
12. Zuscik MJ, Hilton MJ, Zhang X, Chen D, O'Keefe RJ. Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest. 2008;118:429-38.
13. Histing T, Garcia P, Matthys R, Leidinger M, Holstein JH, Kristen A, et al. An internal locking plate to study intramembranous bone healing in a mouse femur fracture model. J Orthop Res. 2010;28:397-402.
14. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res. 2009;24:274-82.
15. Lounev VY, Ramachandran R, Wosczyna MN, Yamamoto M, Maidment AD, Shore EM, et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am. 2009;91:652-63.
16. •• Liu R, Birke O, Morse A, Peacock L, Mikulec K, Little DG, et al. Myogenic progenitors contribute to open but not closed fracture repair. BMC Musculoskelet Disord. 2011;12:288. Muscle lineage cells were genetically traced in a mouse. In a closed tibial fracture model, there was no significant contribution of muscle cells to the healing callus. In contrast, open tibial fractures featuring periosteal stripping and muscle fenestration had up to 50 % of muscle derived stem cells detected in the open fracture callus.
17. Wosczyna MN, Biswas AA, Cogswell CA, Goldhamer DJ. Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J Bone Miner Res. 2012;27:1004-17.
18. • Khosla S, Westendorf JJ, Modder UI. Concise review: insights from normal bone remodeling and stem cell-based therapies for bone repair. Stem Cells. 2010;28:2124-8. A number of animal and human studies have now shown the potential benefit of bone marrow-derived mesenchymal stem cells in enhancing bone repair. However, the effect of marrow-derived cells is more likely due to induction of angiogenesis and recruitment of host progenitor cells rather than direct differentiation into osteoblasts.
19. Zhang X, Xie C, Lin AS, Ito H, Awad H, Lieberman JR, et al. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res. 2005;20:2124-37.
20. Augustin G, Antabak A, Davila S. The periosteum. Part 1: anatomy, histology and molecular biology. Injury. 2007;38:1115-30.
21. Cullen MC, Roy DR, Crawford AH, Assenmacher J, Levy MS, Wen D. Open fracture of the tibia in children. J Bone Joint Surg Am. 1996;78:1039-47.
22. Colnot C, Huang S, Helms J. Analyzing the cellular contribution of bone marrow to fracture healing using bone marrow transplantation in mice. Biochem Biophys Res Commun. 2006;350:557-61.
23. Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res. 2008;26:165-75.
24. • Maes C, Kobayashi T, Selig MK, Torrekens S, Roth SI, Mackem S, et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell. 2010;19:329-44. Osteoblast precursors were found to intimately associate with invading blood vessels, in pericyte-like fashion during bone development and fracture healing.
25. Reverte MM, Dimitriou R, Kanakaris NK, Giannoudis PV. What is the effect of compartment syndrome and fasciotomies on fracture healing in tibial fractures? Injury. 2011;42:1402-7.
26. Liu R, Schindeler A, Little DG. The potential role of muscle in bone repair. J Musculoskelet Neuronal Interact. 2010;10:71-6.
27. Harry LE, Sandison A, Paleolog EM, Hansen U, Pearse MF, Nanchahal J. Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. J Orthop Res. 2008;26:1238-44.
28. •• Hao Y, Ma Y, Wang X, Jin F, Ge S. Short-term muscle atrophy caused by botulinum toxin-A local injection impairs fracture healing in the rat femur. J Orthop Res. 2012;30:574-80. The injection of botulinum toxin-A (BXTA) with induction of muscle paralysis results in marked reduction in fracture healing compared with fracture healing in the contralateral femur.
29. Hou Z, Irgit K, Strohecker KA, Matzko ME, Wingert NC, DeSantis JG, et al. Delayed flap reconstruction with vacuum-assisted closure management of the open IIIB tibial fracture. J Trauma. 2011;71:1705-8.
30. Fleming ME, Watson JT, Gaines RJ, O'Toole RV. Evolution of orthopaedic reconstructive care. J Am Acad Orthop Surg. 2012;20 Suppl 1:S74-9.
31. Pollak AN, McCarthy ML, Burgess AR. Short-term wound complications after application of flaps for coverage of traumatic soft-tissue defects about the tibia. The Lower Extremity Assessment Project (LEAP) Study Group. J Bone Joint Surg Am. 2000;82-A:1681-91.
32. Davis TA, O'Brien FP, Anam K, Grijalva S, Potter BK, Elster EA. Heterotopic ossification in complex orthopaedic combat wounds: quantification and characterization of osteogenic precursor cell activity in traumatized muscle. J Bone Joint Surg Am. 2011;93:1122-31.
33. Kaplan FS, Lounev VY, Wang H, Pignolo RJ, Shore EM. Fibrodysplasia ossificans progressiva: a blueprint for metamorphosis. Ann N Y Acad Sci. 2011;1237:5-10.
34. Tachi K, Takami M, Sato H, Mochizuki A, Zhao B, Miyamoto Y, et al. Enhancement of bone morphogenetic protein-2-induced ectopic bone formation by transforming growth factor-beta1. Tissue Eng Part A. 2011;17:597-606.
35. •• Cairns DM, Liu R, Sen M, Canner JP, Schindeler A, Little DG, et al. Interplay of Nkx3.2, Sox9 and Pax3 regulates chondrogenic differentiation of muscle progenitor cells. PLoS One. 2012;7:e39642. The balance of Pax3, Nkx3.2, and Sox9 may act as a molecular switch during the chondrogenic differentiation of muscle progenitor cells, which may be important for fracture healing.
36. •• Glass GE, Chan JK, Freidin A, Feldmann M, Horwood NJ, Nanchahal J. TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci U S A. 2011;108:1585-90. Bone injury results in increased local TNF-alpha, which promotes MDSC migration followed by osteogenic differentiation.
37. Mithal A, Bonjour JP, Boonen S, Burckhardt P, Degens H, El Hajj Fuleihan G, et al. Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int. 2012. doi: 10.1007/s00198-012-2236-y
38. • Wu CH, Yang KC, Chang HH, Yen JF, Tsai KS, Huang KC. Sarcopenia is related to increased risk for low bone mineral density. J Clin Densitom. 2013;16:98-103. Sarcopenia is a risk factor for low BMD.
39. • Verschueren S, Gielen E, O'Neill TW, Pye SR, Adams JE, Ward KA, et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int. 2013;24:87-98. Sarcopenia is associated with low BMD and osteoporosis in middle-aged and elderly men.
40. Guo YF, Zhang LS, Liu YJ, Hu HG, Li J, Tian Q, et al. Suggestion of GLYAT gene underlying variation of bone size and body lean mass as revealed by a bivariate genome-wide association study. Hum Genet. 2013;132:189-99.
41. Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011;2:153-61.
42. Supasyndh O, Satirapoj B, Aramwit P, Viroonudomphol D, Chaiprasert A, Thanachatwej V, et al. Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8:271-79.
43. Giannoulis MG, Martin FC, Nair KS, Umpleby AM, Sonksen P. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev. 2012;33:314-77.
44. Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci. 2012;67:1140-52.